miami glp-1 legal team law firm in James Campbell to Speak at Cutting-Edge Issues in Asbestos Litigation Conference Dr. Miami GLP-1 Weight Loss

A novel dual GLP-1 and GIP receptor agonist is neuroprotective in the MPTP mouse model of Parkinsons disease by increasing expression of BNDF

Gastrointestinal side effects such as nausea and vomiting may lead to dehydration, resulting in concentrated urine with stronger odour

In 2025, Novo Nordisk submitted Orforglipron for regulatory review by the FDA, but it is not yet approved

Over time, researchers began examining real-world evidence to determine whether the rodent findings translated into measurable human risk

There is also no information on the rate of failed GUS imaging, despite reported failure rates of up to 10% in the literature

Semaglutide is typically used as a long-term treatment for chronic weight management